Case Name: ASTELLAS PHARMA, INC. and Boehringer Ingelheim Pharmaceuticals, Inc., Plaintiffs-Appellees, v. RANBAXY, INC., Ranbaxy Pharmaceuticals, Inc., and Ranbaxy Laboratories, Ltd., Defendants-Appellants
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2007-11-06
Citations: 255 F. App'x 512
Docket Number: No. 2007-1199
Parties: ASTELLAS PHARMA, INC. and Boehringer Ingelheim Pharmaceuticals, Inc., Plaintiffs-Appellees, v. RANBAXY, INC., Ranbaxy Pharmaceuticals, Inc., and Ranbaxy Laboratories, Ltd., Defendants-Appellants.
Judges: 
Reporter: West's Federal Appendix
Volume: 255
Pages: 512–512

Head Matter:
ASTELLAS PHARMA, INC. and Boehringer Ingelheim Pharmaceuticals, Inc., Plaintiffs-Appellees, v. RANBAXY, INC., Ranbaxy Pharmaceuticals, Inc., and Ranbaxy Laboratories, Ltd., Defendants-Appellants.
No. 2007-1199.
United States Court of Appeals, Federal Circuit.
Nov. 6, 2007.

Opinion:
ORDER
Defendants-Appellants Ranbaxy Inc., Ranbaxy Pharmaceuticals Inc., and Ranbaxy Laboratories Limited and PlaintiffsAppellees Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals, Inc., having filed a consented Motion for an Order remanding the pending action to the District Court for further action by that court to effectuate a contingent settlement, and this Court having considered the consented Motion and for good cause shown, it is hereby,
ORDERED that the Motion is GRANTED. This case is remanded to the District Court.